Streamline Health Solutions, Inc. (NASDAQ:STRM – Get Free Report) was the recipient of a large decrease in short interest in February. As of February 15th, there was short interest totalling 21,800 shares, a decrease of 21.9% from the January 31st total of 27,900 shares. Currently, 0.7% of the shares of the stock are short sold. Based on an average daily trading volume, of 29,800 shares, the days-to-cover ratio is currently 0.7 days.
Streamline Health Solutions Price Performance
Streamline Health Solutions stock opened at $3.25 on Thursday. The firm’s 50-day moving average is $3.75 and its two-hundred day moving average is $3.79. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.46 and a quick ratio of 0.46. The stock has a market capitalization of $13.89 million, a P/E ratio of -1.35 and a beta of 1.55. Streamline Health Solutions has a 12-month low of $1.85 and a 12-month high of $9.75.
Streamline Health Solutions (NASDAQ:STRM – Get Free Report) last issued its quarterly earnings results on Monday, December 16th. The company reported ($0.61) earnings per share for the quarter. Streamline Health Solutions had a negative return on equity of 56.96% and a negative net margin of 50.51%.
Wall Street Analyst Weigh In
View Our Latest Stock Analysis on STRM
About Streamline Health Solutions
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
Further Reading
- Five stocks we like better than Streamline Health Solutions
- The 3 Best Blue-Chip Stocks to Buy Now
- 2 Oversold Stocks With Major Reasons to Rebound
- Insider Trading – What You Need to Know
- Robinhood’s Rally: Is Global Expansion the Next Big Catalyst?
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Eli Lilly Pours $27B Into U.S. Growth—What It Means for Investors
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
